rs12645938

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000320.3(QDPR):​c.255C>T​(p.Cys85Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0445 in 1,614,008 control chromosomes in the GnomAD database, including 1,794 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 124 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1670 hom. )

Consequence

QDPR
NM_000320.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.486

Publications

8 publications found
Variant links:
Genes affected
QDPR (HGNC:9752): (quinoid dihydropteridine reductase) This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase. [provided by RefSeq, Jul 2008]
QDPR Gene-Disease associations (from GenCC):
  • dihydropteridine reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.108).
BP6
Variant 4-17504419-G-A is Benign according to our data. Variant chr4-17504419-G-A is described in ClinVar as Benign. ClinVar VariationId is 348160.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.486 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0544 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
QDPRNM_000320.3 linkc.255C>T p.Cys85Cys synonymous_variant Exon 3 of 7 ENST00000281243.10 NP_000311.2
QDPRNM_001306140.2 linkc.162C>T p.Cys54Cys synonymous_variant Exon 2 of 6 NP_001293069.1
QDPRNR_156494.2 linkn.291C>T non_coding_transcript_exon_variant Exon 3 of 6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
QDPRENST00000281243.10 linkc.255C>T p.Cys85Cys synonymous_variant Exon 3 of 7 1 NM_000320.3 ENSP00000281243.5

Frequencies

GnomAD3 genomes
AF:
0.0352
AC:
5348
AN:
152096
Hom.:
125
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00777
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0261
Gnomad ASJ
AF:
0.0225
Gnomad EAS
AF:
0.0604
Gnomad SAS
AF:
0.0412
Gnomad FIN
AF:
0.0746
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0466
Gnomad OTH
AF:
0.0297
GnomAD2 exomes
AF:
0.0405
AC:
10191
AN:
251452
AF XY:
0.0412
show subpopulations
Gnomad AFR exome
AF:
0.00744
Gnomad AMR exome
AF:
0.0156
Gnomad ASJ exome
AF:
0.0240
Gnomad EAS exome
AF:
0.0571
Gnomad FIN exome
AF:
0.0742
Gnomad NFE exome
AF:
0.0458
Gnomad OTH exome
AF:
0.0391
GnomAD4 exome
AF:
0.0454
AC:
66420
AN:
1461794
Hom.:
1670
Cov.:
32
AF XY:
0.0453
AC XY:
32965
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.00660
AC:
221
AN:
33480
American (AMR)
AF:
0.0168
AC:
752
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0241
AC:
629
AN:
26136
East Asian (EAS)
AF:
0.0727
AC:
2888
AN:
39698
South Asian (SAS)
AF:
0.0393
AC:
3386
AN:
86254
European-Finnish (FIN)
AF:
0.0756
AC:
4036
AN:
53416
Middle Eastern (MID)
AF:
0.0170
AC:
98
AN:
5768
European-Non Finnish (NFE)
AF:
0.0466
AC:
51809
AN:
1111922
Other (OTH)
AF:
0.0431
AC:
2601
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3491
6982
10472
13963
17454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1960
3920
5880
7840
9800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0351
AC:
5341
AN:
152214
Hom.:
124
Cov.:
32
AF XY:
0.0359
AC XY:
2669
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00775
AC:
322
AN:
41542
American (AMR)
AF:
0.0261
AC:
399
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0225
AC:
78
AN:
3468
East Asian (EAS)
AF:
0.0599
AC:
310
AN:
5174
South Asian (SAS)
AF:
0.0410
AC:
198
AN:
4830
European-Finnish (FIN)
AF:
0.0746
AC:
789
AN:
10582
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0465
AC:
3163
AN:
68002
Other (OTH)
AF:
0.0298
AC:
63
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
271
543
814
1086
1357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0401
Hom.:
140
Bravo
AF:
0.0301
Asia WGS
AF:
0.0530
AC:
184
AN:
3478
EpiCase
AF:
0.0435
EpiControl
AF:
0.0433

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dihydropteridine reductase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.8
DANN
Benign
0.55
PhyloP100
0.49
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12645938; hg19: chr4-17506042; COSMIC: COSV55549642; API